<SUBMISSION>
<ACCESSION-NUMBER>0001193125-05-196535
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>4
<PERIOD>20051003
<ITEMS>8.01
<ITEMS>9.01
<FILING-DATE>20051005
<DATE-OF-FILING-DATE-CHANGE>20051004
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DAVITA INC
<CIK>0000927066
<ASSIGNED-SIC>8090
<IRS-NUMBER>510354549
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>001-14106
<FILM-NUMBER>051123461
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>601 HAWAII STREET
<CITY>EL SEGUNDO
<STATE>CA
<ZIP>90245
<PHONE>3105362400
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>601 HAWAII STREET
<CITY>EL SEGUNDO
<STATE>CA
<ZIP>90245
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>TOTAL RENAL CARE HOLDINGS INC
<DATE-CHANGED>19950524
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>TOTAL RENAL CARE INC
<DATE-CHANGED>19940719
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="4"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>Form 8-K </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">Date of Report (date of earliest event reported): October&nbsp;3, 2005 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="6"><B>DAVITA INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>1-4034</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>No. 51-0354549</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>jurisdiction of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>601 Hawaii Street
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>El Segundo, California 90245 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>(Address of principal executive offices including Zip Code) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>(310) 536-2400 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Registrant&#146;s telephone number, including area code) </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Not applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>INFORMATION TO BE INCLUDED IN THE REPORT </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;8.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Other Events. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">On October&nbsp;3, 2005, DaVita Inc. (&#147;DaVita&#148;) issued a press release announcing the expected receipt of final approval from the Federal Trade
Commission (&#147;FTC&#148;) of DaVita&#146;s acquisition of Gambro Healthcare U.S. and the anticipated close of the acquisition in early October. A copy of the press release is attached hereto as Exhibit 99.1. </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">On October&nbsp;4, 2005, DaVita issued a press release announcing the
issuance by the FTC of a consent order allowing for the closing of DaVita&#146;s acquisition of Gambro Healthcare U.S. A copy of the press release is attached hereto as Exhibit 99.2. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;9.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Financial Statements and Exhibits. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Exhibits. </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>Exhibit<BR>Number</B></FONT><BR><HR WIDTH="42" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of DaVita Inc., dated October 3, 2005.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">99.2</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of DaVita Inc., dated October 4, 2005.</FONT></TD></TR>
</TABLE>



<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">D<SMALL>A</SMALL>V<SMALL>ITA</SMALL> I<SMALL>NC</SMALL>.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Date: October&nbsp;4, 2005</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT FACE="Times New Roman" SIZE="2">/<SMALL>S</SMALL>/&nbsp;&nbsp;&nbsp;&nbsp;J<SMALL>OSEPH</SMALL>
S<SMALL>CHOHL&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</SMALL></FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>Joseph Schohl</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>Vice President, General Counsel and Secretary</B></FONT></TD></TR>
</TABLE>



<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>EXHIBIT INDEX </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>Exhibit<BR>Number</B></FONT><BR><HR WIDTH="42" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P><HR WIDTH="61" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of DaVita Inc., dated October 3, 2005.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">99.2</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of DaVita Inc., dated October 4, 2005.</FONT></TD></TR>
</TABLE>


</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE OF DAVITA INC.
<TEXT>
<HTML><HEAD>
<TITLE>Press Release of DaVita Inc.</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g37480img01.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Contact:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">LeAnne Zumwalt</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">DaVita Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">650 696-8910</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><U>DaVita to Close
Gambro Healthcare Acquisition in Early October </U></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">El Segundo, California,
October&nbsp;3, 2005 &#150; DaVita Inc. (NYSE: DVA), today announced that it expects to receive final approval of its acquisition of Gambro Healthcare&nbsp;U.S. from the Federal Trade Commission shortly and is working towards closing the acquisition
in early October. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">DaVita is a leading provider of dialysis services for
patients suffering from chronic kidney failure. DaVita operates and provides administrative services to kidney dialysis centers and home peritoneal dialysis programs domestically in 37 states and the District of Columbia. As of June&nbsp;30, 2005,
DaVita operated or provided administrative services at 706 outpatient centers, serving approximately 57,200 patients. </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>dex992.htm
<DESCRIPTION>PRESS RELEASE OF DAVITA INC.
<TEXT>
<HTML><HEAD>
<TITLE>Press Release of DaVita Inc.</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.2 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g37480img01.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Contact:</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">LeAnne Zumwalt</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">DaVita Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">650 696-8910</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><U>Federal Trade
Commission Completes Review </U></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">El Segundo, California, October&nbsp;4, 2005
&#150; DaVita Inc. (NYSE: DVA) announced today that the Federal Trade Commission (FTC) has completed its review of DaVita&#146;s acquisition of Gambro Healthcare U.S. and has issued a consent order&nbsp;allowing for the closing
of&nbsp;the&nbsp;acquisition.&nbsp;The terms of the consent order require DaVita to divest sixty-seven dialysis centers within ten days, and three centers within 60 days, of the completion of its acquisition of Gambro. DaVita has entered into
definitive agreements to sell all of the centers required to be divested. This includes the sale, as previously announced,&nbsp;of&nbsp;substantially all of the required divestitures to Renal Advantage, Inc.&nbsp;DaVita expects to complete the
closing of the Gambro acquisition in early October and&nbsp;the required divestitures within the prescribed timeframe contained in the order. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. DaVita operates and provides administrative services to kidney
dialysis centers and home peritoneal dialysis programs domestically in 37 states and the District of Columbia. As of June&nbsp;30, 2005, DaVita operated or provided administrative services at 706 outpatient centers, serving approximately 57,200
patients. </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g37480img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g37480img01.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!X17AI9@``24DJ``@````&`#$!`@`1
M````5@````$#!0`!````:`````,#`0`!`````-DZ`A!1`0`!`````0```!%1
M!``!````Q`X``!)1!``!````Q`X```````!-:6-R;W-O9G0@3V9F:6-E`'^@
MA@$`C[$``/_;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H<
M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T-
M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,O_``!$(`&`!`P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0``
M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%
M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U
M-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*
MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:
MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#
M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q
M$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8
MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?H
MZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?J***`"BBB@`HHHH`*P_$?BK3?
M#-NC7;/+=3'%O9P+OFF;T5?Z]*FUG59K/R[/3X!<ZI<`F&%CA%`ZO(>R#\R>
M!5?1/"]OI=S)J-W*U]K$X_?7LPYQ_=0=$0=@/QS5Q26LB6V]$<M)IWQ`\7,7
MN[]/#.G,<K;VYWW!7_:88P?Q'THA^"_AP_/?W6IWTY'S22W&"3^`_K7H]%7[
M>:TCIZ$^RB]]3S*\^">AX\S2M0U'3[D?<=9=X!_0_K6#<ZWX\^&5R@U=_P"V
MM&9@HG<D_AOZJ?9LCTKVNH;JTM[ZUDM;J%)H)5VO'(N58>XIQKRVGJB716\-
M&9GAKQ1I?BO3!>Z9/N`XDB;AXF]&';^M;-?/>M:?J/PB\;0ZCIK/+IEP3L5C
MPZ9^:)O<=C]#ZU[MH^K6FNZ3;:G8R;[>X3<I[CU!]P<BBM24;2C\+'3J.7NR
MW1>HHHK`U"BBB@`HHHH`**K:A<-:6$TZ`%HUW`'O5:_U2.#2A<H?GF4>4O<D
MC^E85,13I\W,]E?Y&D*4IVLMW8TJ*:FX1KN^]@9^M.K=:F84444`%%%%`!11
M10`4444`+1110`E5=0-^+*3^S1;&[XV?:2P3KSG;STJU10@/,?&/CKQ1X*CM
M&OK719S=,P1('ER-N,DY[<BH_!WC_P`5^-9KM+'3M(@%LJEWG>7!W9P!COP:
MXKXUZG]L\;)9*V4LK=4(_P!IOF/Z%:[WX):7]C\&2WS+A[VX9@?55^4?J&KO
ME"$:"FUJSDC*4JKBGH=#*_CQ$S'!X=D;^[YDR_KBLM_B%>:!>0VOC'1'TU9C
MM2^MY/.MR?<XR/UKO:S=?T:U\0:)=Z9=HK1SQE02,[&[,/<'FN6,XMVDM#=Q
ME;W6/TN"U\IKVWF6Y:[Q(URI!\P?PX(_A`Z`?S)J_7A7P?\`%5QI>N2>%;^0
MF"5W$&X_ZN5>JCV.#^/UKW6BM3=.=F%*:G&Z"BBBLC0****`.?\`&GAN/Q5X
M7N].95\_;YENY_@E'W3_`$/L37E7P8\32Z;K,_AB])6.X9FA5O\`EG,OWE_$
M`_B/>O=:^<_B;ITWA3XCKJMD/+%PRWL)'02`_,/S&?\`@5=>&?/%TGUV.:O[
MC51'T915/2=2AUC2+34;<YBN8EE7G.,C./PZ5<KD:MH=*=PHHHH`*CF$IC/D
MLJR=1N&0?8U)12:NK#3L[G(ZY?ZH(S;74$<,3_Q)R'_&JFBK#<ZG"+N?"QX\
MM6/4]A[5J:E%)K>KK:0G$%OQ))V!/7\>U79?#.GO'MC5XG'1U8DY_&OEI8/$
M5\3*M!\\8O[3WMT5NS^1[*Q%*G15.7NMKIT-BBH+,3K:HEP0TJ_*S#^+'?\`
M&IZ^HC+FBG:QXS5G8**I7^K:?I:QF]NXH#(X2-6;YG8G`"CJ3GTJ[5V%<***
M*0!1110`4444`+1110`E(2%4L3@`9)I:Y[QSJG]C^"=7O`V'%NR)_O-\H_4T
MXKF:2$W97/F3Q'J3:SXEU+4,[OM%R[K_`+N<*/RQ7U+X6TP:-X5TO3\8:"V1
M6'^UC+?J37S)X+TK^V?&6DV.W<CW"M(/]A?F;]!7UE7=C7;E@CDPJO>3"BBJ
MVH7:V&FW5XY`2"%Y3GT4$_TK@W.P^4[^_:R\;W6H0/S#J+S(RGTD)KZSBD66
M))%(*NH8$>AKXTED:>1Y&.7D8L2>Y)K[$TZ-HM+M(W&&2%%(]PHKT,<K*)QX
M1W<BS15#6-:T_0-.DO\`4[E+>W3^)NK'T`ZD^PK@-/\`'7B7QQ?30>%-.@LM
M/B;:^HWP+8]@@XS[<^^*XXTY25^ATRFHNW4].HKBY[#Q]IL7VJWURQU=HQEK
M.:R$'F#T5U/!],\5DZ]\7[/2=,TNZMM->YEO%<RP/+Y;6[(=K*W!YW9'X4U1
ME)VCJ)U$OBT/2J\M^..DBY\,6FIJO[RSN-K'_8<8/ZA:Z[P3XHE\7Z"=5DT_
M[$AE:.-?-W[P,9;.!WR/PJ3QQIW]J>"-8M-N6:V=U'^THW#]0*=-NG55^C%.
MTZ;L<E\$M8^V^$9M-=B9+"<@`_W'^8?KNKTVOGGX):H;3QG)9%OW=[;,,?[2
M?,/TW5]#56*ARU7YDX>7-304445SFX5$\BR-);QS*LP4$@<E0<X./P/Y5E>(
MM?31H88((Q<:I>-Y5E:@\R/ZGT4=2>PIJVVH:+HDLMK;KJNKR,))MTHA$SG`
M)R0=J@<`>@`JN2ZUZBYK/0UK:VBM(1%"NU1R?4GU/O4U>2>)OBWK7AR^&GW?
MANV@O-@DPU[YH`.<?=4>E=?\/-9U?Q#X;_M?5S$K7,K&".)-JI&./J<D'K5?
M5W3IIVLNA/ME.=NIUE<Q\0=9.A>!]3NXWVS-'Y,1!P=[_*"/IDG\*V=6N=0M
M=/:73-/6_N@0%@:<1`C/)W$'I7A_Q;\2ZU>I8Z/JFE1Z:5/VDHEV)]_55)P!
MC^*KH4G.:[$5JG+%F5\*-+DUOX@6UQ<%YDL4-P[.Q;D<+R?<@_A7TG7AOPG@
M\0Z3I-UJ6F^'8]0CO7"K,]ZL)`3(P`0>Y//M7JVB:CX@O+J1-6T&+3H53*R+
M>K,6;/3``QQGFM,7>4V^B\R,/90]3<HILDB11M)(ZI&@+,S'``'4DUYKJ7Q5
M:_UE-$\&Z>-4O')'GR$K$,=2.Y`]>!]:YX4Y3V-Y34=STRBN,31_'SP>;)XK
ML([@C/D)IH:,'TW$YQ[U4G^(,^AZ)JG]OV,<>LZ:$W01/B.Z#G"O&2.AYSUQ
MBG[)OX7<7M$M]#OJ*\^\"_$J;QKJ\UDNC?98X8?->7[1OQR`!C:.O]*]!I3A
M*#M(<9J2NA:***@H2O*OCGJGV?PW8::K8:[N-[#_`&4'^+#\J]5KYW^-6I_;
M?&Z6:ME+&W5"/]IOF/Z%:Z<)'FJKR,,1*U-EOX&Z7]I\3WNI,N5M+?8I]&<_
MX*?SKWVO-O@GI?V/P7)>LN'OKAG!]57Y1^H:O2:6*ES56/#QM305Q?Q5U8:5
M\/[\!L27>+9.?[W7_P`=#5VE>#_''7A=:U9Z)$V4LT\V7'_/1N@_!?\`T*EA
MX<]1(=>7+!L\^\,:8VL>*-+T]5W>=<H&'^R#EC^0-?5^H7]MI6FW%]=R".VM
MXS([>@%>+?`_PXT^I77B&9/W5NI@MR1U<_>(^@X_X%6_\<M7>U\.V.EQMC[;
M,6D]T3!Q^97\JZ<1^]K*FC"C^[I.;/+]?UW5?B+XNA10P$THAL[;/RQ*3C/U
M[DU](^'M#M/#FAVVEV:@10K@MCEV[L?<FO$?@CHXO?%=SJ4B92P@^0GL[\#]
M`U?0-9XN235..R*PT;IS>["OE/QW-%=^/=9:T`,9NV50O0MT./JV:^E?%&L+
MH'AC4=38\V\+,GNYX4?F17SE\.]);7O'VG12CS$24W,Y/<+\W/U.!^-5@URJ
M51]!8GWG&"/HWPOI`T'POINF#[UO`JO[N>6_4FM61%EC>-QE6!4CU!IU%<3;
M;NSJ2LK'REX>G/A[XA63,2HM=0\ISG^'?M/Z$U]6U\I^/K<V7C_6T4%2+MI%
MY_O?-_6OI_1[P:CHEC>@@BXMTEX]U!KMQBNHS[G+AM'*)=K'\3>)+#PKHLNI
M7[G8ORQQK]Z1ST45:UC5[+0=*GU+4)1';PKN8]R>P`[D]`*\H\,6M[\4/%[>
M)-7B9-$L'Q:6K'*LXZ#WQP6/<X'2N:G3NG*6R-YSM[L=V=?X(TF_O)I/%GB`
M9U2]7%O">EI;GD(H[$]3_P#KKMB<#)Z45S?CW6?["\$ZG>J<2^48HO\`??Y1
M_//X4FW4F/2$3YT\5:A+XG\<7]Q#F0W-UY5N!W4'8GZ`5]0Z+IL>C:)9:;%]
MRVA6+/K@<G\3S7SK\)]%.K^/+1V4F&Q!N7/NO"_^/$?E7TQ73C))6IKH<^%5
M[S?4*^5_'^K'Q!X[U*XB^=!+]GA`[A?E&/J<G\:^CO%VL?V#X3U/4@0'A@;R
M\G^,\+^I%?/'PUT?^W/'NGQRC?%`QNI<\Y"<C/U;%/!I14JCZ!B7S-01]&>&
M=(70?#6G:6O6W@56]VZL?S)K5HK#\9:L^A^#]4U&)MLL,!\L^CGY5_4BN/6<
MO-G3I&/H>/?%GQ_+JE_-X>TV4II]NVVY=#CSY!U7/]T?J?H*[SX2^$TT'PQ'
MJ$\8&H:BHE=B.4CZHH_#D^Y]J\'\,Z4VO^*=.TUB3]IN%$A/)V]6/Y`U]<(J
MHBH@`51@`=A7;B;4H*E$Y:%ZDG4D+7A?QWN+=M:TJW3'VA+=VD(/\)8;0?Q#
M&O=*^5/&VJOXE\=:A<Q9=7G\BW'JJ_*OYXS^-9X*-ZG-V+Q4K0MW/7/@AH_V
M/PK<:FZ8DOISM)[QIP/UW5Z?6=H&EIHF@6&F)TMH%C)]2!R?Q.36C6%6?/-R
M-J<>6*0M%%%9EC20`23@#J:^1?$FI-K/B?4]0'/VBY=D_P!W.%_3%?0NN>+K
MBXT*_@T_P]KYO)8'2'?8,H#$8!)[=:\2T3P9KUOK=A-J'A[5?L<4Z/-MM68E
M0<D`=^E>AA$H7E(X\2^>R1]&^&-,&C>%],T_&#!;(K?[V,M^I-:U<Q_PFD?_
M`$+_`(B_\%S5!=^.9HHB;3PIXBN92/E4V?EC/N2>/R-<;A.3O8Z5.*5C8\2^
M(+3PQH-SJEXPVQ+A$[R.?NJ/J:^:-*TK5_B!XLD6,%[BZE,US-CY85)Y8^PZ
M`?05Z/?^#/&GQ$U6*[\0F+1].C/[JV#[V0'KA1QN/<DCZ=J].\.>&-+\*Z:+
M+3(`BGF21N7E;U8]_P"E=,)QH1=M9/\``PE"5:6ND46=%T>TT#1[;3+%-MO;
MIM7/4GN3[DY->5?'NVE-OHET!^Z1Y8V/HQ"D?^@G\J]DK#\6^&[?Q7X=N-*G
M;8SX:*7&?+D'1OZ'V)K"C4Y:BFS:K#F@XHXGX%VBQ^%;^[Q\\UX5)QV51C^9
MKU*O'/`VJW/PW%WH/BFRN+:V>8RP7L<321,2`",J#UP"/QS79OX_MM1!M_#-
ME=:O>-PI$+QPQGUDD8``>PR:NO"4JCDMGU(I2C&"3W.0^.7B%(K"S\/PN#+,
MPN)P.R#A0?J<G_@-0_`C1\1:IK3C[Q%K%^'S-_-?RJ#XA?#W45\.IK)+:EK1
MN#+J$L2GE"H`"+_<7`P.O)-2^`?&HTWP7!H>DZ->W>NAI-L0B(B)9B0[/T"@
M$9^E;Z?5^6&O<R_Y?<TSUY;^T?49-/2XC:[CC$KP@_,JDX!(_"K-<]X4\.R:
M):3W%_.+K6+Y_.O;D#AF[*OHJC@"NAKADDG9'6FVM3YH^+EOY'Q'U`A0!*D4
MG'?*`?S%>Q_#W6+=/A?IM]>7"10VL#)+(YP%",1_("O*?C7$J>/0ZYS)9QLW
MURP_I7(C7-4N]`M?#,))M!<&188U^:61CP#ZX/0>]>FZ7M:,$<"J>SJR9V>K
M:KJ?Q=\9P:78AH-+A8L@/1$!YE?_`&CT`]P/6O>=*TNTT72[?3K&(1VUN@1%
M_J?<]:YOX=^#(_!^@A)0K:E<@/=2#L>R#V'ZG)KL*XJ]1-\D/A1U4H->]+=A
M7C?QWU<K;Z7HR-]]FN91[#Y5_4M^5>R5XQ\:?"VJW^I6>M6-K+=0);^1,L*E
MFCPQ()`YP=WZ486WM5<,1?V;L:'P-T7[-H-[K$BX>\E\N,_["?\`V1/Y5Z5)
MJUC%J\.E-<+]NFB:9(0"3L4@$GTZ]Z\W\%>*]33PC8:-I'A6_>_MX_*,MPOE
M6RG)^<N>3UR0!FNW\.>'3I+7%_?SB\UF](:ZNMN!QTC0=D'8?B:*ZO.4I"I:
M12B<)\==6,&B:=I*-AKF8RN`?X4''ZL/RJO\"='"66IZTZ_-*XMHC_LK\S?J
M1^56/C-X3U3618:KIMM)=?9D:.:*(9<`G(8#OWS2_#SQ9#I'@ZWT@:'K$NI0
M,^8([1OWA+$YW'"J.>YXK9?[MRQ^9G_R_O(]+U;5;/1-,GU"^E\N"%<D]V/9
M0.Y)X`KD_&YO=9^$NHS3V36ER]N)FMBV]D57#8)'?:,GTJ]IVAZCJVIQ:UXF
M$8>$[K+3(VW1VQ_OL?XY/?H.U=1-%'/#)#*@>.12KJ>A!X(KF34&K:M&[3DF
M?._P6M5N/'WFMC-O:22+]20O_LQKZ+KQ&U\/ZE\+/'1U6*QGOM`F#Q-);H9'
MBC8@X8#G(('/<"O0!\2O#<R[;*:[OK@CY;:VLY6D8^F"H'YFM\2G4ES1U1E0
M:A'EEHRQX_\`$:>&?"%Y>!P+F1?)MQW,C#`/X<G\*\'^%^CG6?'M@KKOBM2;
MJ3/^STS_`,"*UZMK/A#5_&>G:AJ&M1)!<FV=-*T[?D6Q.#O=AP9#@#T`KS_X
M9Z[;>"M9U1-9T[4%NY8UBC2.W9G!!)*X]^/RK2C:-*2CK(BK=U(N6Q[_`'>H
M6EBUNMU<1Q-<2B&$.<%W/11[\5.[I&`795!.`2<<UQWA[3-4UK6QXH\0P?9F
M12FFZ<W)M4/5V_VV'Y"N9^)*3-KA%V76%HA]F=U)B\L1R&10!QYA;9@=3\HZ
M9KEC23ERW-W4:CS6/6J*P_!ZSKX7LQ/]HX,GE?:?]9Y/F-Y6[/.?+V=>?7FB
MLI*SL:)W5S;HHHI#"BBB@`HHHH`****`"C&***`"C`':BB@`HHHH`^?_`(YQ
MJGC"RD`^9[(;N?1VK:^#O@4KM\3ZG#R1_H,;CH.\F/T'XGTKHO%?@5_%OQ#T
M^XNT(TFUM`9F_P">K;V(C']?;ZUZ$D:Q1K'&H5%`5548``Z`5V3KVHJ$?F<T
M:-ZCFQU%%%<9TA1110`4444`%%%%`!1110`48`[444`%&!G-%%`!1C-%%`"T
&444`?__9
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
